Skip to main content
. 2011 Apr 12;97(11):923–930. doi: 10.1136/hrt.2010.216309

Table 1.

Baseline (phase 3) and follow-up (phase 7) characteristics of the 4469 study participants

Baseline (1991–3) Phase 7 (2003–4)
N %/Mean (SD) N %/Mean (SD)
Sex
 Men 3217 72.0
 Women 1252 28.0
Age (years)
 <45 1198 26.8
 45–55 2169 48.5
 ≥55 1102 24.7
 All 4469 49.3 (5.9)
Ethnicity
 White 4189 93.7
 Non-white 280 6.3
Education
 No or lower secondary 1969 44.1
 A-levels 1171 26.2
 University or higher 1329 29.7
BMI (kg/m2)
 Normal (<25) 2463 55.1 1718 38.4
 Overweight (25–30) 1667 37.3 1999 44.7
 Obese (≥30) 339 7.6 752 16.8
 All 4469 25.0 (3.5) 4469 26.5 (4.2)
Current smoking
 No 4000 89.5 4159 93.1
 Yes 469 10.5 310 6.9
Long-standing illness
 No 2993 67.0 1767 39.5
 Yes 1476 33.0 2702 60.5
Total cholesterol concentrations (mmol/l) 4469 6.4 (1.1) 4469 5.7 (1.0)
HDL-cholesterol concentrations (mmol/l) 4469 1.4 (0.4) 4469 1.6 (0.4)
Triglyceride concentrations (mmol/l) 4469 1.3 (0.7) 4469 1.3 (0.7)
LDL-cholesterol concentrations (mmol/l) 4469 4.4 (1.0) 4469 3.5 (0.9)
Lipid-lowering drugs use
 No 4435 99.2 3987 89.2
 Yes 34 0.8 482 10.8
AHEI score, mean (SD) 4469 50.7 (11.9) 4469 51.2 (12.5)
Physical activity (h/week) 4469 3.4 (3.4) 4469 3.7 (3.1)

AHEI, alternate healthy eating index; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.